25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

180 Life Sciences Corp
Buy, Hold or Sell?

Let's analyze 180 Life Sciences Corp together

I guess you are interested in 180 Life Sciences Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of 180 Life Sciences Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about 180 Life Sciences Corp

I send you an email if I find something interesting about 180 Life Sciences Corp.

1. Quick Overview

1.1. Quick analysis of 180 Life Sciences Corp (30 sec.)










1.2. What can you expect buying and holding a share of 180 Life Sciences Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.3%

What is your share worth?

Current worth
$1.89
Expected worth in 1 year
$3.85
How sure are you?
47.8%

+ What do you gain per year?

Total Gains per Share
$1.96
Return On Investment
90.5%

For what price can you sell your share?

Current Price per Share
$2.17
Expected price per share
$1.16 - $3.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of 180 Life Sciences Corp (5 min.)




Live pricePrice per Share (EOD)
$2.17
Intrinsic Value Per Share
$52.73 - $65.66
Total Value Per Share
$54.62 - $67.55

2.2. Growth of 180 Life Sciences Corp (5 min.)




Is 180 Life Sciences Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$3.7m$6.2m-$5.7m-1,021.5%

How much money is 180 Life Sciences Corp making?

Current yearPrevious yearGrowGrow %
Making money-$780.4k-$10.1m$9.3m1,195.7%
Net Profit Margin-345.8%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of 180 Life Sciences Corp (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#707 / 945

Most Revenue
#674 / 945

Most Profit
#220 / 945

Most Efficient
#580 / 945
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of 180 Life Sciences Corp?

Welcome investor! 180 Life Sciences Corp's management wants to use your money to grow the business. In return you get a share of 180 Life Sciences Corp.

First you should know what it really means to hold a share of 180 Life Sciences Corp. And how you can make/lose money.

Speculation

The Price per Share of 180 Life Sciences Corp is $2.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 180 Life Sciences Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 180 Life Sciences Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.89. Based on the TTM, the Book Value Change Per Share is $0.49 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 180 Life Sciences Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-19.5%-0.39-18.2%-2.69-124.2%-2.03-93.4%-1.85-85.5%
Usd Book Value Change Per Share2.1096.8%0.4922.6%-3.32-152.8%-1.04-47.8%0.083.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.073.4%0.063.0%
Usd Total Gains Per Share2.1096.8%0.4922.6%-3.32-152.8%-0.96-44.4%0.156.7%
Usd Price Per Share1.67-1.47-1.74-4.41-5.17-
Price to Earnings Ratio-0.99-16.77--0.22-3.00--6.60-
Price-to-Total Gains Ratio0.80-5.22--1.73-0.59-1.58-
Price to Book Ratio0.88--3.76--1.67--0.37--0.29-
Price-to-Total Gains Ratio0.80-5.22--1.73-0.59-1.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.17
Number of shares460
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.07
Usd Book Value Change Per Share0.49-1.04
Usd Total Gains Per Share0.49-0.96
Gains per Quarter (460 shares)225.88-443.33
Gains per Year (460 shares)903.50-1,773.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10904894136-1909-1783
2018071798272-3818-3556
3027112702407-5727-5329
4036143606543-7636-7102
5045184510679-9546-8875
6054215414815-11455-10648
7063256318951-13364-12421
80722872221086-15273-14194
90813281261222-17182-15967
100903590301358-19091-17740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%6.017.00.026.1%6.017.00.026.1%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%9.010.01.045.0%11.011.01.047.8%11.011.01.047.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.022.04.3%1.00.022.04.3%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%9.010.01.045.0%11.011.01.047.8%11.011.01.047.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of 180 Life Sciences Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.1000.491+328%-3.316+258%-1.038+149%0.082+2457%
Book Value Per Share--1.8890.282+569%3.168-40%10.150-81%14.800-87%
Current Ratio--0.1920.488-61%0.946-80%0.521-63%0.548-65%
Debt To Asset Ratio--0.6431.013-36%0.621+4%0.531+21%0.471+37%
Debt To Equity Ratio--1.8040.451+300%0.714+153%0.590+206%0.650+178%
Dividend Per Share----0%-0%0.074-100%0.064-100%
Enterprise Value---3239572.000-1315704.250-59%-18529.750-99%7345332.506-144%18633190.266-117%
Eps---0.423-0.395-7%-2.694+537%-2.028+379%-1.855+338%
Ev To Ebitda Ratio--1.0010.324+209%0.028+3512%-1.493+249%-13.033+1402%
Ev To Sales Ratio--infnannan%nannan%nannan%nannan%
Free Cash Flow Per Share---0.113-0.340+201%-1.478+1207%-1.041+820%-0.921+714%
Free Cash Flow To Equity Per Share---0.354-0.282-20%-0.108-69%3.150-111%1.591-122%
Gross Profit Margin--1.0000.501+100%1.0000%0.900+11%0.913+9%
Intrinsic Value_10Y_max--65.658--------
Intrinsic Value_10Y_min--52.731--------
Intrinsic Value_1Y_max---3.177--------
Intrinsic Value_1Y_min---3.127--------
Intrinsic Value_3Y_max---2.111--------
Intrinsic Value_3Y_min---2.165--------
Intrinsic Value_5Y_max--7.921--------
Intrinsic Value_5Y_min--6.712--------
Market Cap4290090.000+23%3301590.0002898282.000+14%3446405.250-4%17240675.206-81%17636257.918-81%
Net Profit Margin----3.4580%-0%-0.6920%-0.6010%
Operating Margin----3.7730%-0%-0.7550%-0.6560%
Operating Ratio---5.024-100%-0%1.005-100%0.874-100%
Pb Ratio1.149+23%0.884-3.765+526%-1.671+289%-0.370+142%-0.287+132%
Pe Ratio-1.282-30%-0.98616.768-106%-0.221-78%2.998-133%-6.603+569%
Price Per Share2.170+23%1.6701.466+14%1.743-4%4.411-62%5.173-68%
Price To Free Cash Flow Ratio-4.795-30%-3.690-0.933-75%-0.290-92%-7.792+111%-9.717+163%
Price To Total Gains Ratio1.033+23%0.7955.224-85%-1.733+318%0.593+34%1.583-50%
Quick Ratio--0.0310.233-87%0.750-96%0.759-96%55.381-100%
Return On Assets---0.080-0.155+94%-0.941+1078%-0.306+283%-0.267+235%
Return On Equity---0.224-0.056-75%-0.783+249%-0.302+35%-0.299+33%
Total Gains Per Share--2.1000.491+328%-3.316+258%-0.964+146%0.146+1336%
Usd Book Value--3733774.000558397.000+569%6262579.500-40%21122105.500-82%30176772.130-88%
Usd Book Value Change Per Share--2.1000.491+328%-3.316+258%-1.038+149%0.082+2457%
Usd Book Value Per Share--1.8890.282+569%3.168-40%10.150-81%14.800-87%
Usd Dividend Per Share----0%-0%0.074-100%0.064-100%
Usd Enterprise Value---3239572.000-1315704.250-59%-18529.750-99%7345332.506-144%18633190.266-117%
Usd Eps---0.423-0.395-7%-2.694+537%-2.028+379%-1.855+338%
Usd Free Cash Flow---223659.000-672480.000+201%-2922241.000+1207%-2352840.300+952%-2076576.087+828%
Usd Free Cash Flow Per Share---0.113-0.340+201%-1.478+1207%-1.041+820%-0.921+714%
Usd Free Cash Flow To Equity Per Share---0.354-0.282-20%-0.108-69%3.150-111%1.591-122%
Usd Market Cap4290090.000+23%3301590.0002898282.000+14%3446405.250-4%17240675.206-81%17636257.918-81%
Usd Price Per Share2.170+23%1.6701.466+14%1.743-4%4.411-62%5.173-68%
Usd Profit---836720.000-780447.000-7%-10112571.250+1109%-5898286.400+605%-5309788.217+535%
Usd Revenue---83015.000-100%-0%16603.000-100%14437.391-100%
Usd Total Gains Per Share--2.1000.491+328%-3.316+258%-0.964+146%0.146+1336%
 EOD+6 -2MRQTTM+20 -15YOY+17 -155Y+18 -1910Y+16 -21

3.3 Fundamental Score

Let's check the fundamental score of 180 Life Sciences Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.282
Price to Book Ratio (EOD)Between0-11.149
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.031
Current Ratio (MRQ)Greater than10.192
Debt to Asset Ratio (MRQ)Less than10.643
Debt to Equity Ratio (MRQ)Less than11.804
Return on Equity (MRQ)Greater than0.15-0.224
Return on Assets (MRQ)Greater than0.05-0.080
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of 180 Life Sciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.540
Ma 20Greater thanMa 502.397
Ma 50Greater thanMa 1002.768
Ma 100Greater thanMa 2002.357
OpenGreater thanClose2.090
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About 180 Life Sciences Corp

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.

Fundamental data was last updated by Penke on 2024-12-05 13:06:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit 180 Life Sciences Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 180 Life Sciences Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-345.8%+345.8%
TTM-345.8%YOY--345.8%
TTM-345.8%5Y-69.2%-276.7%
5Y-69.2%10Y-60.1%-9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.4%+109.4%
TTM-345.8%-221.4%-124.4%
YOY--208.7%+208.7%
5Y-69.2%-346.2%+277.0%
10Y-60.1%-470.4%+410.3%
4.3.1.2. Return on Assets

Shows how efficient 180 Life Sciences Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • -8.0% Return on Assets means that 180 Life Sciences Corp generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 180 Life Sciences Corp:

  • The MRQ is -8.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.0%TTM-15.5%+7.5%
TTM-15.5%YOY-94.1%+78.6%
TTM-15.5%5Y-30.6%+15.1%
5Y-30.6%10Y-26.7%-3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%-11.6%+3.6%
TTM-15.5%-12.0%-3.5%
YOY-94.1%-11.2%-82.9%
5Y-30.6%-12.6%-18.0%
10Y-26.7%-14.2%-12.5%
4.3.1.3. Return on Equity

Shows how efficient 180 Life Sciences Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • -22.4% Return on Equity means 180 Life Sciences Corp generated $-0.22 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 180 Life Sciences Corp:

  • The MRQ is -22.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.4%TTM-5.6%-16.8%
TTM-5.6%YOY-78.3%+72.7%
TTM-5.6%5Y-30.2%+24.6%
5Y-30.2%10Y-29.9%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.4%-14.5%-7.9%
TTM-5.6%-16.0%+10.4%
YOY-78.3%-14.6%-63.7%
5Y-30.2%-18.6%-11.6%
10Y-29.9%-19.3%-10.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of 180 Life Sciences Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient 180 Life Sciences Corp is operating .

  • Measures how much profit 180 Life Sciences Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 180 Life Sciences Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-377.3%+377.3%
TTM-377.3%YOY--377.3%
TTM-377.3%5Y-75.5%-301.8%
5Y-75.5%10Y-65.6%-9.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--203.3%+203.3%
TTM-377.3%-316.3%-61.0%
YOY--216.5%+216.5%
5Y-75.5%-378.6%+303.1%
10Y-65.6%-480.3%+414.7%
4.3.2.2. Operating Ratio

Measures how efficient 180 Life Sciences Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.024-5.024
TTM5.024YOY-+5.024
TTM5.0245Y1.005+4.019
5Y1.00510Y0.874+0.131
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.284-2.284
TTM5.0243.198+1.826
YOY-3.263-3.263
5Y1.0054.651-3.646
10Y0.8746.419-5.545
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of 180 Life Sciences Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if 180 Life Sciences Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.19 means the company has $0.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.192. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.488. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.192TTM0.488-0.296
TTM0.488YOY0.946-0.459
TTM0.4885Y0.521-0.033
5Y0.52110Y0.548-0.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1923.601-3.409
TTM0.4883.872-3.384
YOY0.9464.655-3.709
5Y0.5215.973-5.452
10Y0.5486.258-5.710
4.4.3.2. Quick Ratio

Measures if 180 Life Sciences Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • A Quick Ratio of 0.03 means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.031. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.233. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.031TTM0.233-0.202
TTM0.233YOY0.750-0.517
TTM0.2335Y0.759-0.526
5Y0.75910Y55.381-54.622
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0313.093-3.062
TTM0.2333.416-3.183
YOY0.7504.393-3.643
5Y0.7595.954-5.195
10Y55.3816.436+48.945
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of 180 Life Sciences Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of 180 Life Sciences Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 180 Life Sciences Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.64 means that 180 Life Sciences Corp assets are financed with 64.3% credit (debt) and the remaining percentage (100% - 64.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.643. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 1.013. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ0.643TTM1.013-0.370
TTM1.013YOY0.621+0.392
TTM1.0135Y0.531+0.482
5Y0.53110Y0.471+0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6430.345+0.298
TTM1.0130.346+0.667
YOY0.6210.311+0.310
5Y0.5310.365+0.166
10Y0.4710.382+0.089
4.5.4.2. Debt to Equity Ratio

Measures if 180 Life Sciences Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 180.4% means that company has $1.80 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 1.804. The company is just able to pay all its debts with equity.
  • The TTM is 0.451. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.804TTM0.451+1.353
TTM0.451YOY0.714-0.263
TTM0.4515Y0.590-0.139
5Y0.59010Y0.650-0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8040.393+1.411
TTM0.4510.431+0.020
YOY0.7140.384+0.330
5Y0.5900.452+0.138
10Y0.6500.497+0.153
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings 180 Life Sciences Corp generates.

  • Above 15 is considered overpriced but always compare 180 Life Sciences Corp to the Biotechnology industry mean.
  • A PE ratio of -0.99 means the investor is paying $-0.99 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 180 Life Sciences Corp:

  • The EOD is -1.282. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.986. Based on the earnings, the company is expensive. -2
  • The TTM is 16.768. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-1.282MRQ-0.986-0.295
MRQ-0.986TTM16.768-17.755
TTM16.768YOY-0.221+16.989
TTM16.7685Y2.998+13.770
5Y2.99810Y-6.603+9.601
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.282-2.259+0.977
MRQ-0.986-2.480+1.494
TTM16.768-3.148+19.916
YOY-0.221-3.244+3.023
5Y2.998-5.991+8.989
10Y-6.603-6.692+0.089
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 180 Life Sciences Corp:

  • The EOD is -4.795. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.690. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.933. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.795MRQ-3.690-1.105
MRQ-3.690TTM-0.933-2.757
TTM-0.933YOY-0.290-0.643
TTM-0.9335Y-7.792+6.859
5Y-7.79210Y-9.717+1.925
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.795-2.995-1.800
MRQ-3.690-3.289-0.401
TTM-0.933-3.668+2.735
YOY-0.290-4.472+4.182
5Y-7.792-8.001+0.209
10Y-9.717-9.190-0.527
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of 180 Life Sciences Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.88 means the investor is paying $0.88 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 180 Life Sciences Corp:

  • The EOD is 1.149. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.884. Based on the equity, the company is cheap. +2
  • The TTM is -3.765. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.149MRQ0.884+0.265
MRQ0.884TTM-3.765+4.649
TTM-3.765YOY-1.671-2.094
TTM-3.7655Y-0.370-3.394
5Y-0.37010Y-0.287-0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1492.001-0.852
MRQ0.8842.054-1.170
TTM-3.7652.385-6.150
YOY-1.6712.431-4.102
5Y-0.3703.690-4.060
10Y-0.2874.307-4.594
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of 180 Life Sciences Corp.

4.8.1. Institutions holding 180 Life Sciences Corp

Institutions are holding 3.455% of the shares of 180 Life Sciences Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30UBS Group AG0.34630684768470
2024-09-30Tower Research Capital LLC0.11810.00012335-3934-62.7532
2024-06-30BlackRock Inc0.039077200
2024-06-30Bank of America Corp0.0006012120
2024-06-30Royal Bank of Canada0.000601100
2024-09-30Semmax Financial Advisors Inc.0.0001021100
2024-09-30Qube Research & Technologies000-2-100
2024-06-30Wells Fargo & Co000-4-100
2024-09-30JPMorgan Chase & Co000-1-100
2024-06-30IFP Advisors, LLC000-1-100
2024-06-30Charles Schwab Investment Management Inc000-18364-100
2024-06-30Citadel Advisors Llc000-739-100
Total 0.50470.00019979-16185-162.2%

4.9.2. Funds holding 180 Life Sciences Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.23960473600
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.12750252100
2024-09-30Fidelity Total Market Index0.0052010200
2024-09-30Fidelity Series Total Market Index0.003907700
2024-09-30Northern Trust Extended Eq Market Idx0.002504900
2024-09-30NT Ext Equity Mkt Idx Fd - L0.002504900
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.002404800
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.00203900
2024-10-31State St US Extended Mkt Indx NL Cl C0.000901700
2024-09-30BNYM Mellon SL Market Completion UC10.000701400
2024-09-30Northern Trust Wilshire 50000.00050900
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00040800
2024-10-31State St US Ttl Mkt Indx SL Cl I0.00040800
2024-06-30SSgA U.S. Total Market Index Strategy0.000407240
2024-09-30BNYM Mellon NSL Mkt Completion Fund Inst0.00010200
Total 0.38907686+2+0.0%

5.3. Insider Transactions

Insiders are holding 4.343% of the shares of 180 Life Sciences Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-31Jr. Donald A McgovernBUY52621.85
2023-05-18James N WoodyBUY210519.57
2023-05-18Ozan PamirBUY27119.19
2023-05-18Pamela G MarroneBUY37220.14
2021-12-16Quan Anh VuBUY211512.4
2021-12-10Ozan PamirBUY101470.6
2021-12-10Quan Anh VuBUY111482
2021-12-09James N WoodyBUY321622.6
2021-12-09Jr. Donald A McgovernBUY651569.4
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Total Stockholder Equity -14922-128-827-954536-4184,1523,734



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets10,470
Total Liabilities6,736
Total Stockholder Equity3,734
 As reported
Total Liabilities 6,736
Total Stockholder Equity+ 3,734
Total Assets = 10,470

Assets

Total Assets10,470
Total Current Assets1,225
Long-term Assets9,244
Total Current Assets
Cash And Cash Equivalents 195
Other Current Assets 1,030
Total Current Assets  (as reported)1,225
Total Current Assets  (calculated)1,225
+/-0
Long-term Assets
Intangible Assets 9,244
Long-term Assets  (as reported)9,244
Long-term Assets  (calculated)9,244
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,384
Long-term Liabilities352
Total Stockholder Equity3,734
Total Current Liabilities
Short-term Debt 473
Accounts payable 2,091
Other Current Liabilities 3,820
Total Current Liabilities  (as reported)6,384
Total Current Liabilities  (calculated)6,384
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)352
Long-term Liabilities  (calculated)0
+/- 352
Total Stockholder Equity
Common Stock0
Retained Earnings -129,238
Accumulated Other Comprehensive Income -2,983
Other Stockholders Equity 135,955
Total Stockholder Equity (as reported)3,734
Total Stockholder Equity (calculated)3,734
+/-0
Other
Cash and Short Term Investments 195
Common Stock Shares Outstanding 981
Liabilities and Stockholders Equity 10,470
Net Debt 278
Net Working Capital -5,158
Short Long Term Debt Total 473



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
116,813
117,026
117,058
117,308
117,955
118,221
0
118,437
50,237
51,573
51,884
51,884
50,372
11,024
50,372
60,112
55,533
65,070
62,714
59,677
53,358
34,336
19,650
14,922
13,667
4,958
5,259
3,442
3,911
10,470
10,4703,9113,4425,2594,95813,66714,92219,65034,33653,35859,67762,71465,07055,53360,11250,37211,02450,37251,88451,88451,57350,237118,4370118,221117,955117,308117,058117,026116,813
   > Total Current Assets 
608
486
470
391
597
543
0
271
209
901
748
748
553
721
553
8,298
4,015
13,634
11,201
8,957
4,647
6,515
8,928
4,196
2,934
3,371
3,640
1,855
2,347
1,225
1,2252,3471,8553,6403,3712,9344,1968,9286,5154,6478,95711,20113,6344,0158,2985537215537487489012092710543597391470486608
       Cash And Cash Equivalents 
578
454
428
340
543
519
0
271
110
836
83
83
70
474
70
6,053
2,109
11,688
8,225
5,669
1,625
3,589
6,970
2,646
2,009
2,663
1,976
676
1,146
195
1951,1466761,9762,6632,0092,6466,9703,5891,6255,6698,22511,6882,1096,053704747083838361102710519543340428454578
       Short-term Investments 
116,206
116,540
116,588
116,917
117,358
117,678
0
118,166
0
0
0
11,878
0
10,303
10,303
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000010,30310,303011,878000118,1660117,678117,358116,917116,588116,540116,206
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
328
328
357
0
357
300
785
0
695
0
2,035
2,510
621
357
89
130
279
10
10
0
01010279130893576212,5102,0350695078530035703573283280000000000
       Other Current Assets 
0
0
0
0
0
0
0
10
99
65
337
35
6
-10,056
125
0
14
1,946
50
3,288
11
2,926
1,958
1,550
926
708
1,385
1,169
1,191
1,030
1,0301,1911,1691,3857089261,5501,9582,926113,288501,946140125-10,0566353376599100000000
   > Long-term Assets 
116,206
116,540
116,588
116,917
117,358
117,678
0
118,166
50,028
50,672
51,136
51,136
49,820
10,303
49,820
51,814
51,518
51,436
51,513
50,721
48,710
27,821
10,722
10,726
10,732
1,587
1,620
1,587
1,564
9,244
9,2441,5641,5871,6201,58710,73210,72610,72227,82148,71050,72151,51351,43651,51851,81449,82010,30349,82051,13651,13650,67250,028118,1660117,678117,358116,917116,588116,540116,206
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
54
54
44
0
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004404454540000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
36,423
36,423
35,339
0
35,339
37,183
36,901
36,896
36,988
36,324
34,589
13,966
0
0
0
0
0
0
0
0
0000000013,96634,58936,32436,98836,89636,90137,18335,339035,33936,42336,4230000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
14,659
14,659
14,436
0
14,436
14,631
14,618
14,540
14,525
14,397
14,121
13,855
10,722
10,726
10,732
1,587
1,620
1,587
1,564
9,244
9,2441,5641,5871,6201,58710,73210,72610,72213,85514,12114,39714,52514,54014,61814,63114,436014,43614,65914,6590000000000
       Long-term Assets Other 
116,206
116,540
116,588
116,917
117,358
117,678
0
118,166
0
0
0
11,980
0
10,303
10,303
0
12,570
12,569
0
12,530
12,411
12,291
-15,656
9,063
9,063
0
0
0
0
0
000009,0639,063-15,65612,29112,41112,530012,56912,570010,30310,303011,980000118,1660117,678117,358116,917116,588116,540116,206
> Total Liabilities 
4,138
4,264
4,233
4,309
4,745
4,691
0
4,571
5,456
6,813
13,314
13,314
14,490
4,003
14,490
37,403
25,247
27,929
23,391
18,773
10,566
8,261
8,306
7,783
6,951
5,107
5,387
4,396
4,329
6,736
6,7364,3294,3965,3875,1076,9517,7838,3068,26110,56618,77323,39127,92925,24737,40314,4904,00314,49013,31413,3146,8135,4564,57104,6914,7454,3094,2334,2644,138
   > Total Current Liabilities 
113
239
208
284
720
666
0
546
1,431
2,788
9,641
9,641
8,060
4,003
8,060
33,622
21,421
24,225
19,699
15,077
6,966
4,725
5,658
5,122
4,273
4,807
5,063
4,080
4,016
6,384
6,3844,0164,0805,0634,8074,2735,1225,6584,7256,96615,07719,69924,22521,42133,6228,0604,0038,0609,6419,6412,7881,4315460666720284208239113
       Short-term Debt 
0
0
0
0
0
0
0
0
0
2,005
3,528
3,528
586
1,838
586
1,707
3,668
361
1,909
1,383
889
406
1,309
842
588
333
1,300
772
429
473
4734297721,3003335888421,3094068891,3831,9093613,6681,7075861,8385863,5283,5282,005000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
586
0
3,668
1,707
1,564
361
1,909
1,383
889
406
1,309
842
588
333
1,034
772
429
0
04297721,0343335888421,3094068891,3831,9093611,5641,7073,6680586000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
4,104
4,104
4,714
358
4,714
3,905
8,529
639
587
1,039
1,591
1,015
1,801
1,208
837
1,713
1,893
1,837
2,920
2,091
2,0912,9201,8371,8931,7138371,2081,8011,0151,5911,0395876398,5293,9054,7143584,7144,1044,1040000000000
       Other Current Liabilities 
113
239
208
284
720
666
0
546
1,431
2,788
2,009
2,009
2,760
2,165
2,760
24,385
4,443
20,885
15,220
12,655
4,486
3,303
2,548
3,072
8
6
3,762
1,471
667
3,820
3,8206671,4713,762683,0722,5483,3034,48612,65515,22020,8854,44324,3852,7602,1652,7602,0092,0092,7881,4315460666720284208239113
   > Long-term Liabilities 
4,025
4,025
4,025
4,025
4,025
4,025
0
4,025
4,025
4,025
3,673
3,673
6,430
6,251
6,430
3,781
3,825
3,704
3,692
3,696
3,600
3,536
2,649
2,661
2,678
301
325
316
313
352
3523133163253012,6782,6612,6493,5363,6003,6963,6923,7043,8253,7816,4306,2516,4303,6733,6734,0254,0254,02504,0254,0254,0254,0254,0254,025
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,484
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,48400000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
3,673
0
3,484
2,022
3,711
3,673
3,680
3,652
3,644
3,652
3,563
3,504
0
0
2,651
0
0
0
0
0
000002,651003,5043,5633,6523,6443,6523,6803,6733,7112,0223,48403,6730000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
12,537
0
0
0
12,570
12,589
12,615
3,652
12,576
12,530
12,411
12,291
0
0
9,063
0
0
0
0
0
000009,0630012,29112,41112,53012,5763,65212,61512,58912,57000012,5370000000000
> Total Stockholder Equity
5,000
5,000
5,000
5,000
5,000
5,000
0
5,000
5,000
5,000
38,571
38,571
35,882
5,000
35,882
22,709
30,287
37,141
39,323
40,905
42,791
26,075
11,344
7,140
6,716
-149
-128
-954
-418
3,734
3,734-418-954-128-1496,7167,14011,34426,07542,79140,90539,32337,14130,28722,70935,8825,00035,88238,57138,5715,0005,0005,00005,0005,0005,0005,0005,0005,000
   Common Stock
107,675
107,762
107,825
107,999
108,210
108,529
0
108,866
39,781
39,759
1
1
0
1
0
3
3
3
3
3
3
4
0
0
1
1
0
0
0
0
0000110043333330101139,75939,781108,8660108,529108,210107,999107,825107,762107,675
   Retained Earnings 
-29
57
121
294
505
825
0
1,161
1,382
1,360
-37,474
-37,474
-39,587
-3,343
-39,587
-64,556
-48,358
-69,719
-68,682
-67,119
-64,179
-85,666
-107,409
-112,171
-115,851
-126,117
-127,344
-128,413
-128,402
-129,238
-129,238-128,402-128,413-127,344-126,117-115,851-112,171-107,409-85,666-64,179-67,119-68,682-69,719-48,358-64,556-39,587-3,343-39,587-37,474-37,4741,3601,3821,161082550529412157-29
   Capital Surplus 
0
0
0
0
0
0
0
0
0
3,639
3,930
4,147
9,583
12,680
9,583
0
78,005
106,154
0
0
0
0
0
0
0
0
0
0
0
0
000000000000106,15478,00509,58312,6809,5834,1473,9303,639000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
-102,646
-102,819
-102,946
-103,293
-103,715
-104,354
0
-105,027
-36,163
-36,119
75,890
75,890
76,293
8,343
76,293
826
78,005
106,154
107,184
107,930
108,786
115,427
121,638
122,195
125,466
128,815
130,117
130,354
130,899
135,955
135,955130,899130,354130,117128,815125,466122,195121,638115,427108,786107,930107,184106,15478,00582676,2938,34376,29375,89075,890-36,119-36,163-105,0270-104,354-103,715-103,293-102,946-102,819-102,646



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-106
Gross Profit-106-106
 
Operating Income (+$)
Gross Profit-106
Operating Expense-13,478
Operating Income-13,478-13,583
 
Operating Expense (+$)
Research Development2,785
Selling General Administrative10,693
Selling And Marketing Expenses10,646,406,413
Operating Expense13,47810,646,419,890
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-41
Net Interest Income-41
 
Pretax Income (+$)
Operating Income-13,478
Net Interest Income-41
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-22,285-4,670
EBIT - interestExpense = -22,240
-22,285
-19,935
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-22,240-22,284
Earnings Before Interest and Taxes (EBITDA)-22,134
 
After tax Income (+$)
Income Before Tax-22,285
Tax Provision--3,288
Net Income From Continuing Ops-40,450-18,997
Net Income-19,935
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,478
Total Other Income/Expenses Net-8,80741
 

Technical Analysis of 180 Life Sciences Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 180 Life Sciences Corp. The general trend of 180 Life Sciences Corp is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 180 Life Sciences Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 180 Life Sciences Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.1 < 2.775 < 3.75.

The bearish price targets are: 1.16.

Tweet this
180 Life Sciences Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 180 Life Sciences Corp. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

180 Life Sciences Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 180 Life Sciences Corp. The current macd is -0.23444497.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 180 Life Sciences Corp price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for 180 Life Sciences Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the 180 Life Sciences Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
180 Life Sciences Corp Daily Moving Average Convergence/Divergence (MACD) Chart180 Life Sciences Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 180 Life Sciences Corp. The current adx is 38.24.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy 180 Life Sciences Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
180 Life Sciences Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 180 Life Sciences Corp. The current sar is 2.729312.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
180 Life Sciences Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 180 Life Sciences Corp. The current rsi is 38.54. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
180 Life Sciences Corp Daily Relative Strength Index (RSI) Chart180 Life Sciences Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 180 Life Sciences Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the 180 Life Sciences Corp price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
180 Life Sciences Corp Daily Stochastic Oscillator Chart180 Life Sciences Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 180 Life Sciences Corp. The current cci is -85.60701574.

180 Life Sciences Corp Daily Commodity Channel Index (CCI) Chart180 Life Sciences Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 180 Life Sciences Corp. The current cmo is -35.47933324.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
180 Life Sciences Corp Daily Chande Momentum Oscillator (CMO) Chart180 Life Sciences Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 180 Life Sciences Corp. The current willr is -86.4516129.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
180 Life Sciences Corp Daily Williams %R Chart180 Life Sciences Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 180 Life Sciences Corp. The current atr is 0.38636445.

180 Life Sciences Corp Daily Average True Range (ATR) Chart180 Life Sciences Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 180 Life Sciences Corp. The current obv is 153,034,945.

180 Life Sciences Corp Daily On-Balance Volume (OBV) Chart180 Life Sciences Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 180 Life Sciences Corp. The current mfi is 56.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
180 Life Sciences Corp Daily Money Flow Index (MFI) Chart180 Life Sciences Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 180 Life Sciences Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

180 Life Sciences Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 180 Life Sciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.540
Ma 20Greater thanMa 502.397
Ma 50Greater thanMa 1002.768
Ma 100Greater thanMa 2002.357
OpenGreater thanClose2.090
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of 180 Life Sciences Corp with someone you think should read this too:
  • Are you bullish or bearish on 180 Life Sciences Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 180 Life Sciences Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 180 Life Sciences Corp

I send you an email if I find something interesting about 180 Life Sciences Corp.


Comments

How you think about this?

Leave a comment

Stay informed about 180 Life Sciences Corp.

Receive notifications about 180 Life Sciences Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.